Literature DB >> 20689545

Turning on the angiogenic microswitch.

Hanna M Eilken, Ralf H Adams.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20689545     DOI： 10.1038/nm0810-853

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

Review 1.  microRNAs join the p53 network--another piece in the tumour-suppression puzzle.

Authors:  Lin He; Xingyue He; Scott W Lowe; Gregory J Hannon
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

Review 2.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

Review 3.  MicroRNAs add a new dimension to cardiovascular disease.

Authors:  Eric M Small; Robert J A Frost; Eric N Olson
Journal:  Circulation       Date:  2010-03-02       Impact factor: 29.690

Review 4.  RASA1: variable phenotype with capillary and arteriovenous malformations.

Authors:  Laurence M Boon; John B Mulliken; Miikka Vikkula
Journal:  Curr Opin Genet Dev       Date:  2005-06       Impact factor: 5.578

5.  miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator.

Authors:  Dimitrios Lagos; Gabriel Pollara; Stephen Henderson; Fiona Gratrix; Martin Fabani; Richard S B Milne; Frances Gotch; Chris Boshoff
Journal:  Nat Cell Biol       Date:  2010-04-25       Impact factor: 28.824

6.  Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein.

Authors:  M Henkemeyer; D J Rossi; D P Holmyard; M C Puri; G Mbamalu; K Harpal; T S Shih; T Jacks; T Pawson
Journal:  Nature       Date:  1995-10-26       Impact factor: 49.962

7.  Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model.

Authors:  Li Ma; Ferenc Reinhardt; Elizabeth Pan; Jürgen Soutschek; Balkrishen Bhat; Eric G Marcusson; Julie Teruya-Feldstein; George W Bell; Robert A Weinberg
Journal:  Nat Biotechnol       Date:  2010-03-28       Impact factor: 54.908

Review 8.  The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth.

Authors:  Gavin Thurston; Irene Noguera-Troise; George D Yancopoulos
Journal:  Nat Rev Cancer       Date:  2007-05       Impact factor: 60.716

9.  Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.

Authors:  Hsei-Wei Wang; Matthew W B Trotter; Dimitrios Lagos; Dimitra Bourboulia; Stephen Henderson; Taija Mäkinen; Stephen Elliman; Adrienne M Flanagan; Kari Alitalo; Chris Boshoff
Journal:  Nat Genet       Date:  2004-06-27       Impact factor: 38.330

Review 10.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582
View more
  9 in total

Review 1.  Making microvascular networks work: angiogenesis, remodeling, and pruning.

Authors:  Axel R Pries; Timothy W Secomb
Journal:  Physiology (Bethesda)       Date:  2014-11

2.  Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.

Authors:  Victoria Stepanova; Padma-Sheela Jayaraman; Sergei V Zaitsev; Tatiana Lebedeva; Khalil Bdeir; Rachael Kershaw; Kelci R Holman; Yelena V Parfyonova; Ekaterina V Semina; Irina B Beloglazova; Vsevolod A Tkachuk; Douglas B Cines
Journal:  J Biol Chem       Date:  2016-05-04       Impact factor: 5.157

Review 3.  Interactions between VEGFR and Notch signaling pathways in endothelial and neural cells.

Authors:  Jean-Leon Thomas; Kasey Baker; Jinah Han; Charles Calvo; Harri Nurmi; Anne C Eichmann; Kari Alitalo
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

Review 4.  Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation.

Authors:  Carlos Mas-Moruno; Florian Rechenmacher; Horst Kessler
Journal:  Anticancer Agents Med Chem       Date:  2010-12       Impact factor: 2.505

5.  Notch signaling regulates the lifespan of vascular endothelial cells via a p16-dependent pathway.

Authors:  Yohko Yoshida; Yuka Hayashi; Masayoshi Suda; Kaoru Tateno; Sho Okada; Junji Moriya; Masataka Yokoyama; Aika Nojima; Masakatsu Yamashita; Yoshio Kobayashi; Ippei Shimizu; Tohru Minamino
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

6.  The "inherent vice" in the anti-angiogenic theory may cause the highly metastatic cancer to spread more aggressively.

Authors:  Denian Wang; Chun Tan; Fei Xiao; Lan Zou; Lijun Wang; Yong'gang Wei; Hanshuo Yang; Wei Zhang
Journal:  Sci Rep       Date:  2017-05-24       Impact factor: 4.379

7.  miR-148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF-1α under non-hypoxia/hypoxia conditions.

Authors:  Hsiang-Lin Tsai; Zhi-Feng Miao; Yi-Ting Chen; Ching-Wen Huang; Yung-Sung Yeh; I-Ping Yang; Jaw-Yuan Wang
Journal:  J Cell Mol Med       Date:  2019-03-04       Impact factor: 5.310

8.  MiR-148a inhibits angiogenesis by targeting ERBB3.

Authors:  Jing Yu; Qi Li; Qing Xu; Lingzhi Liu; Binghua Jiang
Journal:  J Biomed Res       Date:  2011-05

9.  Novel insights into the mechanism of cell-based therapy after chronic myocardial infarction.

Authors:  Alexander Schuh; Britta Butzbach; Adelina Curaj; Sakine Simsekyilmaz; Octavian Bucur; Isabela Kanzler; Bernd Deneke; Simone Konschalla; Andreas Kroh; Tolga Taha Sönmez; Nikolaus Marx; Elisa A Liehn
Journal:  Discoveries (Craiova)       Date:  2014-01-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.